Article
Epigenetic Dysregulation of Myeloproliferative Neoplasms.
Hematology/oncology clinics of North America - 1 Apr 2021
Dunbar Andrew, Park Young, Levine Ross
Abstract excerpt
This article reviews the genetic data on epigenetic modifying mutations in myeloproliferative neoplasms and their clinical implications, preclinical studies exploring our current understanding of how mutations in epigenetic modifying proteins cooperate with myeloproliferative neoplasms drivers to promote disease progression, and recent advances in novel therapeutics supporting the role of targeting epigenetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
